Amino Acid Injection Shortage: Current FDA Update
Areazine synthesizes this FDA drug-shortage notice directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Amino Acid Injection, used in gastroenterology, is experiencing a current shortage with some presentations unavailable from Baxter Healthcare, first posted in 2020 and updated in 2026.
What this FDA drug-shortage notice tells you, and what most readers miss
This notice was issued by FDA on April 8, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - Drug Shortages - determines the regulatory framework behind it, which shapes what mitigations (alternative therapies, allocation timelines, manufacturer guidance) are available and which agency holds oversight.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are drug-shortage, fda, medication, Amino Acid Injection.
What's in Shortage
The generic drug Amino Acid Injection, with brand names PROSOL, TRAVASOL, CLINISOL, and PREMASOL - SULFITE-FREE (AMINO ACID), is currently in shortage. It is an injection dosage form in the gastroenterology therapeutic category. The shortage was first posted on 12/08/2020 and last updated on 04/01/2026.
Which Manufacturers Are Affected
All affected products are from Baxter Healthcare. Their availability status includes:
- PROSOL 20% SULFITE FREE IN PLASTIC CONTAINER: Available.
- Travasol (NDC 0338-0644-04): Unavailable, with estimated recovery TBD.
- Travasol (NDC 0338-0644-03): Available.
- Clinisol 15% Sulfite Free In Plastic Container (NDC 0338-0502-06): Available.
- Travasol (NDC 0338-0644-06): Available.
- Premasol 10% Sulfite Free in VIAFLEX Plastic Container (NDC 0338-1130-04): Available.
- Premasol 10% Sulfite Free in VIAFLEX Plastic Container (NDC 0338-1130-06): Available.
- Clinisol 15% Sulfite Free In Plastic Container (NDC 0338-0502-03): Available.
- Premasol 10% Sulfite Free in VIAFLEX Plastic Container (NDC 0338-1130-03): Available. Contact information for Baxter Healthcare is 888-229-0001.
Why There's a Shortage
No specific reason for the shortage has been provided.
What Patients Should Do
Patients who depend on Amino Acid Injection should talk to their pharmacist or healthcare provider to check on availability and discuss next steps. They can also contact the manufacturer, Baxter Healthcare, at 888-229-0001 for more details. Please remember that patients should always consult their healthcare provider for any medication-related concerns and not make changes without professional advice.
Source
This information is attributed to the FDA Drug Shortage Database.
Original source: FDA Official Notice ↗
Related Drug Shortages
All Drug Shortages →Nationwide notices with similar length or severity timing 8
Two Areazine-derived peer sets for this FDA drug-shortage notice: nearest notices by body length and by same severity near the same agency date. Peers come from other categories so they are not the same-feed Related list above.
Similar body length
Nearest notices by article body length (1,740 characters here).
Similar severity timing
Same severity (medium) notices issued closest in time to April 8, 2026.
Frequently Asked Questions
Common questions about this FDA drug-shortage notice.